Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis

Episode 3 (January 5, 2024): Interview with co-founder and CEO of Moonwalk Biosciences and former CTO of Illumina, Alex Aravanis; Neuro gene therapy with Novartis and Voyager; GEN reporters look forward to the 2024 J.P. Morgan Healthcare Conference.

Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base:

Novartis, Voyager Ink Up-to-$1.3B Expansion of Neuro Gene Therapy Collaboration
By Alex Philippidis, GEN, January 2, 2024.

Moonwalk Biosciences Raises $57M to Edit the Epigenome
By Uduak Thomas, GEN, January 4, 2024.

 

To access all episodes of Touching Base click here.